M. Frier

1.8k total citations
63 papers, 1.4k citations indexed

About

M. Frier is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, M. Frier has authored 63 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Radiology, Nuclear Medicine and Imaging, 20 papers in Pulmonary and Respiratory Medicine and 15 papers in Surgery. Recurrent topics in M. Frier's work include Radiopharmaceutical Chemistry and Applications (20 papers), Medical Imaging Techniques and Applications (10 papers) and Medical Imaging and Pathology Studies (10 papers). M. Frier is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (20 papers), Medical Imaging Techniques and Applications (10 papers) and Medical Imaging and Pathology Studies (10 papers). M. Frier collaborates with scholars based in United Kingdom, United States and Netherlands. M. Frier's co-authors include Alan C. Perkins, S.S. Davis, Lisbeth Illum, Nicholas S. Jones, C G Wilson, N.W. Thomas, John G. Hardy, Lisbeth Ilium, W. B. Hugo and Clive Wilson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Advanced Drug Delivery Reviews.

In The Last Decade

M. Frier

63 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Frier United Kingdom 19 460 398 281 235 177 63 1.4k
Kamel Besseghir Switzerland 21 398 0.9× 434 1.1× 102 0.4× 83 0.4× 130 0.7× 34 1.3k
Robert M. Taylor United Kingdom 29 284 0.6× 467 1.2× 264 0.9× 156 0.7× 378 2.1× 86 2.3k
Andrew J. S. Jones United States 26 506 1.1× 1.7k 4.2× 559 2.0× 184 0.8× 228 1.3× 67 2.8k
C G Wilson United Kingdom 17 462 1.0× 168 0.4× 195 0.7× 96 0.4× 79 0.4× 37 1.2k
Megumu Higaki Japan 25 194 0.4× 307 0.8× 140 0.5× 76 0.3× 62 0.4× 48 1.5k
James Evans United States 26 134 0.3× 467 1.2× 96 0.3× 175 0.7× 189 1.1× 81 1.5k
Nicholas J. Boylan United States 15 731 1.6× 761 1.9× 191 0.7× 495 2.1× 42 0.2× 18 1.9k
Marc Aprahamian France 30 507 1.1× 783 2.0× 67 0.2× 381 1.6× 539 3.0× 102 2.7k
Puneet Tyagi United States 18 324 0.7× 428 1.1× 208 0.7× 61 0.3× 46 0.3× 48 1.2k
Nancy Martin United States 18 76 0.2× 393 1.0× 108 0.4× 232 1.0× 215 1.2× 47 2.4k

Countries citing papers authored by M. Frier

Since Specialization
Citations

This map shows the geographic impact of M. Frier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Frier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Frier more than expected).

Fields of papers citing papers by M. Frier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Frier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Frier. The network helps show where M. Frier may publish in the future.

Co-authorship network of co-authors of M. Frier

This figure shows the co-authorship network connecting the top 25 collaborators of M. Frier. A scholar is included among the top collaborators of M. Frier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Frier. M. Frier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Garnier, Philippe, Mark Robinson, Sander van Kasteren, et al.. (2010). Lectin-directed enzyme activated prodrug therapy (LEAPT): Synthesis and evaluation of rhamnose-capped prodrugs. Journal of drug targeting. 18(10). 794–802. 26 indexed citations
2.
Hunt, Alice E., M. Frier, Randall S. Johnson, Stephen Berezenko, & Alan C. Perkins. (2005). Preparation of Tc-99m-macroaggregated albumin from recombinant human albumin for lung perfusion imaging. European Journal of Pharmaceutics and Biopharmaceutics. 62(1). 26–31. 24 indexed citations
3.
Frier, M.. (2004). Rhenium-188 and Copper-67 Radiopharmaceuticals for the Treatment of Bladder Cancer. Mini-Reviews in Medicinal Chemistry. 4(1). 61–68. 10 indexed citations
4.
Stevens, Howard N.E., Clive Wilson, Peter G. Welling, et al.. (2002). Evaluation of Pulsincap™ to provide regional delivery of dofetilide to the human GI tract. International Journal of Pharmaceutics. 236(1-2). 27–34. 53 indexed citations
5.
Carney, A. Simon, Nicholas S. Jones, M. Frier, et al.. (2001). The effect of the nasal cycle on mucociliary clearance. Clinical Otolaryngology. 26(1). 9–15. 41 indexed citations
6.
Perkins, Alan C., M. Frier, M. L. Wastie, et al.. (2001). Imaging for staging bladder cancer: a clinical study of intravenous 111 indium‐labelled anti‐MUC1 mucin monoclonal antibody C595. British Journal of Urology. 87(1). 39–46. 19 indexed citations
7.
Perkins, Alan C., Clive Wilson, M. Frier, et al.. (2001). The use of scintigraphy to demonstrate the rapid esophageal transit of the oval film-coated placebo risedronate tablet compared to a round uncoated placebo tablet when administered with minimal volumes of water. International Journal of Pharmaceutics. 222(2). 295–303. 26 indexed citations
8.
Frier, M., et al.. (1999). Evaluation of the clearance characteristics of bioadhesive systems in humans. International Journal of Pharmaceutics. 178(1). 55–65. 294 indexed citations
9.
Molthoff, Carla F.M., Peter Kenemans, Jan C. Roos, et al.. (1998). Biodistribution of 111 In-labelled engineered human antibody CTM01 (hCTM01) in ovarian cancer patients: influence of prior administration of unlabelled hCTM01. Cancer Immunology Immunotherapy. 47(1). 39–46. 16 indexed citations
10.
Perkins, Alan C., et al.. (1997). Human biodistribution of an ultrasound contrast agent (Quantison) by radiolabelling and gamma scintigraphy.. British Journal of Radiology. 70(834). 603–611. 18 indexed citations
11.
Bishop, M.C., Alan C. Perkins, M. Frier, et al.. (1997). Preclinical evaluation of copper-67 labelled anti-MUC1 mutin antibody C595 for therapeutic use in bladder cancer. European Journal of Nuclear Medicine and Molecular Imaging. 24(4). 439–443. 29 indexed citations
12.
Frier, M., Joan D. Ellis, & M. Aslam. (1996). Stability of radiopharmaceuticals during administration to the intensive care patient. Journal of Clinical Pharmacy and Therapeutics. 21(3). 149–153. 2 indexed citations
13.
Frier, M., Alan C. Perkins, M. V. Pimm, & Ferenc Hudecz. (1995). Genetically engineered and synthetic macromolecules as radiophameceuticals with potential for liver, lung, blood pool and tumor imaging. Nuclear Medicine Communications. 16(4). 240–240. 1 indexed citations
14.
Perkins, Alan C. & M. Frier. (1994). Experimental biodistribution studies of 99mTc-recombinant human serum albumin (rHSA): a new generation of radiopharmaceutical. European Journal of Nuclear Medicine and Molecular Imaging. 21(11). 1231–3. 9 indexed citations
15.
Frier, M.. (1994). Leucocyte Radiolabelling Techniques: Practical Aspects. Scandinavian Journal of Gastroenterology. 29(sup203). 32–35. 3 indexed citations
16.
Frier, M. & Alan C. Perkins. (1994). Radiopharmaceuticals and the gastrointestinal tract. European Journal of Nuclear Medicine and Molecular Imaging. 21(11). 1234–42. 11 indexed citations
17.
Mahida, Yashwant R., Alan C. Perkins, M. Frier, M. L. Wastie, & C J Hawkey. (1992). Monoclonal antigranulocyte antibody imaging in inflammatory bowel disease. Nuclear Medicine Communications. 13(1). 330–335. 17 indexed citations
18.
Frier, M., et al.. (1991). Anomalies in reduction-mediated technetium-99m labelling of monoclonal antibodies. European Journal of Nuclear Medicine and Molecular Imaging. 18(12). 973–6. 8 indexed citations
19.
WHALLEY, D. R., Keith Priestley, M. Frier, M. L. Wastie, & Robert A. Wilcox. (1988). A comparison of planar and tomographic imaging of the myocardium using 99Tcm-t-butyl isonitrile. Nuclear Medicine Communications. 9(5). 375–381. 1 indexed citations
20.
Frier, M., et al.. (1976). Physical properties of radioactive colloids used in nuclear medicine [proceedings].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 28 Suppl. 42P–42P. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kamel Besseghir Breakdown of academic impact, for papers by Robert M. Taylor Breakdown of academic impact, for papers by Andrew J. S. Jones Breakdown of academic impact, for papers by C G Wilson Breakdown of academic impact, for papers by Megumu Higaki Breakdown of academic impact, for papers by James Evans Breakdown of academic impact, for papers by Nicholas J. Boylan Breakdown of academic impact, for papers by Marc Aprahamian Breakdown of academic impact, for papers by Puneet Tyagi Breakdown of academic impact, for papers by Nancy Martin
Rankless by CCL
2026